Professor Christophe Leclercq
Hospital Pontchaillou of Rennes, Rennes (France)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Smaller trials, trial updates, and other studies: devices, cardiac arrest and atrial fibrillation ablation
Event: ESC Congress 2024
Topic: European Society of Cardiology
Session type: Late-Breaking Science
Leadless vs. transvenous devices: efficacy and safety
Event: ESC Congress 2024
Topic: Device Therapy
Session type: Abstract Sessions
Late breaking clinical trials: devices
Event: Heart Failure 2024
Topic: Heart Failure Association (HFA)
Session type: Late-Breaking Science
Atrial fibrillation 2
Event: Heart Failure 2024
Topic: Atrial Fibrillation (AF)
Session type: Moderated ePosters
The association forum: cardiovascular prevention beyond EAPC
Event: ESC Preventive Cardiology 2024
Topic: Risk Factors and Prevention
Session type: Symposium
Conduction system pacing - Cardiac resynchronisation therapy
Event: EHRA 2024
Topic: Device Therapy
Session type: Abstract Sessions
Atrial fibrillation and cancer: what you should do
Event: ESC Congress 2023
Topic: Cardio-Oncology
Session type: Symposium
Young Investigator Award - Clinical
Event: EHRA 2023
Topic: Arrhythmias, General
Session type: Award Sessions
Anticoagulation for AF in ESC and Asia common or different perspectives?
Event: ESC Asia 2022 with APSC & AFC
Topic: Arrhythmias, General
Session type: Symposium
Hot Line: Miscellaneous
Event: ESC Asia 2022 with APSC & AFC
Topic: Other
Session type: Hot Line
- …
